<div id="readability-page-1"><p>Revolution Medicines, Inc. (<span>RVMD</span>) has disclosed a new risk, in the Share Price &amp; Shareholder Rights category.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>From an external perspective, Revolution Medicines, Inc. faces warrant-related risks that could either dilute existing shareholders or leave warrant holders with securities that expire worthless. If the share price falls below the implied per-share exercise price before the December 2026 expiry, these warrants could lose all value, while remaining exercisable could introduce meaningful dilution.</p> <p>Investors must weigh the uncertainty of the warrants staying in the money against the potential dilution that could occur if they are exercised in large volumes before expiration.</p> <p>The average RVMD <span>stock price target</span> is $176.95, implying 24.17% upside potential.</p> <p>To learn more about Revolution Medicines, Inc.’s risk factors, <span>click here</span>.</p></div>

RVMD

LABU

<p>Revolution Medicines, Inc. (RVMD) has highlighted risks associated with its warrants, which may dilute existing shareholders or become worthless if the share price falls below the exercise price before the December 2026 expiry. Investors must consider the potential for dilution against the uncertainty of the warrants retaining value. The average stock price target for RVMD is $176.95, indicating a 24.17% upside potential.</p>

Tip Ranks

Revolution Medicines

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

iShares Biotechnology ETF

SPDR S&P Biotech

REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)

Revolution Medicines Warrants: Balancing Dilution Risk and Potential Worthlessness Ahead of 2026 Expiry